Inventor · disambiguated record
Marcel Linschoten
Also filed as: LINSCHOTEN MARCEL
11 granted patents·2 pending applications·150 citations·filing 1998–2015
89Inventor score
Top patents by PatentIndex Score
13 records- 0189US6716834B2Thiochromane derivatives and their use as thrombin inhibitorsASTRAZENECA AB·Filed 2001·Granted Apr 6, 2004·25 cites·15 claims
- 0288US6576657B2Amidino derivatives and their use as thrombin inhibitorsASTRAZENECA AB·Filed 2001·Granted Jun 10, 2003·22 cites·18 claims
- 0380US7872052B2Use of heterocyclic compounds as SCCE inhibitorsAREXIS AB·Filed 2004·Granted Jan 18, 2011·16 cites·24 claims
- 0480US6265397B1Amidino derivatives and their use as thrombin inhibitorsASTRAZENECA AB·Filed 1998·Granted Jul 24, 2001·25 cites·18 claims
- 0579US6750243B1Amidino derivatives and their use as thrombin inhibitorsASTRAZENECA AB·Filed 1999·Granted Jun 15, 2004·21 cites·14 claims
- 0672US7071175B1Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitorsASTRAZENECA AB·Filed 2000·Granted Jul 4, 2006·8 cites·23 claims
- 0771US6337394B2CompoundsASTRAZENECA AB·Filed 1998·Granted Jan 8, 2002·33 cites·9 claims
- 0862US2007249578A1New amidino derivatives and their use as thrombin inhibitorsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0955US7241757B2Amidino derivatives and their use as thrombin inhibitorsASTRAZENECA AB·Filed 2004·Granted Jul 10, 2007·0 cites·16 claims
- 1050US7423012B2Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitorsASTRAZENECA AB·Filed 2005·Granted Sep 9, 2008·0 cites·14 claims
- 1146US2008051451A1Autoimmune conditions and NADPH oxidase defectsLINSCHOTEN MARCEL·Filed 2007·Application pending·0 cites
- 1244US7354895B1Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitorsASTRAZENECA AB·Filed 2000·Granted Apr 8, 2008·0 cites·14 claims
- 1331US9744148B2Kallikrein 7 inhibitorsSIXERA PHARMA AB·Filed 2015·Granted Aug 29, 2017·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →